NCT05429580View on ClinicalTrials.gov

Prophylactic Tranexamic Acid Use After Vaginal Delivery

NACompletedINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Postpartum HemorrhageVaginal DeliveryProphylactic Tranexamic Acid Use
Interventions
DRUG

Tranexamic acid

given intravenous tranexamic acid

OTHER

5% Dextrose

given placebo.

Trial Locations (1)

16110

Nefise Nazlı YENIGUL, Bursa

All Listed Sponsors
collaborator

Sisli Hamidiye Etfal Training and Research Hospital

OTHER

lead

Sanliurfa Mehmet Akif Inan Education and Research Hospital

OTHER

NCT05429580 - Prophylactic Tranexamic Acid Use After Vaginal Delivery | Biotech Hunter | Biotech Hunter